Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amidotricoic Acid
2. Amidotrizoate, Meglumine
3. Angiografin
4. Diatrizoate Methylglucamine
5. Diatrizoate, Meglumine
6. Diatrizoate, Methylglucamine
7. Diatrizoic Acid Methylglucamine
8. Gastrograffin
9. Gastrografin
10. Gastrographin
11. Ioxeol
12. Meglumine Amidotrizoate
13. Meglumine Diatrizoate
14. Meglumine, Diatrizoate
15. Methylglucamine Diatrizoate
16. Methylglucamine, Diatrizoate
17. Methylglucamine, Diatrizoic Acid
18. Reno 60
19. Reno M Dip
20. Reno M-dip
21. Reno Mdip
22. Renograffin
23. Renografin
24. Renografin M 76
25. Renografin M-76
26. Renografin M76
27. Sinografin
28. Triombrast
29. Triombrin
30. Urografin
31. Urografin 76
32. Urovist
33. Verografin
1. Meglumine Diatrizoate
2. 131-49-7
3. Meglumine Amidotrizoate
4. Renografin
5. Cardiografin
6. Cystografin
7. Renovist
8. Renocal
9. Angiovist 282
10. Diatrizoate Methylglucamine
11. Reno
12. Urovist Cysto
13. Urovist Cysto Pediatric
14. Urovist Meglumine Diu/ct
15. Meglumine Amidotrizoate Injection
16. Diatrizoate Meglumine [usp]
17. 131-49-7 (meglumine)
18. Diatrizoic Acid Meglumine Salt
19. 3x9mr4n98u
20. Angiografin
21. Urovist
22. 1-deoxy-1-(methylamino)-d-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt)
23. Renurix
24. Unipaque
25. Hypaque Meglumine
26. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol 3,5-diacetamido-2,4,6-triiodobenzoate
27. Cystographin Dilute
28. Diatrizoate Meglumine (usp)
29. Reno-m
30. Reno-m-dip
31. Benzoic Acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
32. Hypaque 60
33. Renograffin M-76
34. Hypaque M 30
35. Hypaque 13.4
36. Reno-30
37. Hypaque-cysto
38. Reno-dip
39. Cystografin Dilute
40. Reno M 60
41. Gastrografin Oral (veterinary)
42. Reno-60
43. Md 60
44. Einecs 205-024-7
45. Unii-3x9mr4n98u
46. Hypaque (tn)
47. Urovist (tn)
48. Reno (tn)
49. 3,5-bis(acetamido)-2,4,6-triiodbenzoesaeure, 1-desoxy-1-methylamino-d-glucit-salz
50. Benzoic Acid, 3,5-diacetamido-2,4,6-triiodo-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol
51. Schembl107036
52. Chembl1200839
53. Dtxsid20897171
54. Hms2234f23
55. Diatrizoate Meglumine [vandf]
56. Meglumine Amidotrizoate [mart.]
57. Glucitol, 1-deoxy-1-(methylamino)-, 3,5-diacetamido-2,4,6-triiodobenzoate (salt), D-
58. Meglumine Amidotrizoate [who-dd]
59. Diatrizoate Meglumine [green Book]
60. Diatrizoate Meglumine [orange Book]
61. Diatrizoic Acid Meglumine Salt [mi]
62. Diatrizoate Meglumine [usp Monograph]
63. Renocal Component Diatrizoate Meglumine
64. Angiovist Component Diatrizoate Meglumine
65. D02015
66. Meglumine Amidotrizoate Injection [jan]
67. Renovist Component Diatrizoate Meglumine
68. Diatrizoate Meglumine Component Of Renocal
69. Gastrovist Component Diatrizoate Meglumine
70. Renografin Component Diatrizoate Meglumine
71. Sinografin Component Diatrizoate Meglumine
72. Diatrizoate Meglumine Component Of Angiovist
73. Diatrizoate Meglumine Component Of Renovist
74. Gastrografin Component Diatrizoate Meglumine
75. Diatrizoate Meglumine Component Of Gastrovist
76. Diatrizoate Meglumine Component Of Renografin
77. Diatrizoate Meglumine Component Of Sinografin
78. Md-gastroview Component Diatrizoate Meglumine
79. Diatrizoate Meglumine Component Of Gastrografin
80. Q27114690
81. Diatrizoate Meglumine Component Of Md-gastroview
| Molecular Weight | 809.1 g/mol |
|---|---|
| Molecular Formula | C18H26I3N3O9 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 808.8803 g/mol |
| Monoisotopic Mass | 808.8803 g/mol |
| Topological Polar Surface Area | 209 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 525 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Cystografin |
| Drug Label | Cystografin is a radiopaque contrast agent supplied as a sterile, clear, colorless to pale yellow, mobile or slightly viscous solution. Each mL provides 300 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of sol... |
| Active Ingredient | Diatrizoate meglumine |
| Dosage Form | Solution |
| Route | Urethral |
| Strength | 30% |
| Market Status | Prescription |
| Company | Bracco |
| 2 of 6 | |
|---|---|
| Drug Name | Cystografin dilute |
| Drug Label | Cystografin Dilute (Diatrizoate Meglumine Injection USP 18%) is a radiopaque contrast agent supplied as a sterile, aqueous solution. Each mL provides 180 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of soluti... |
| Active Ingredient | Diatrizoate meglumine |
| Dosage Form | Solution |
| Route | Urethral |
| Strength | 18% |
| Market Status | Prescription |
| Company | Bracco |
| 3 of 6 | |
|---|---|
| Drug Name | Sinografin |
| Drug Label | Sinografin (Diatrizoate Meglumine and lodipamide Meglumine Injection) is a sterile, nonpyrogenic, essentially colorless to pale yellow, aqueous radiopaque contrast medium for intrauterine instillation. Each mL provides 527 mg diatrizoate meglumine an... |
| Active Ingredient | Diatrizoate meglumine; iodipamide meglumine |
| Dosage Form | Solution |
| Route | Intrauterine |
| Strength | 26.8%; 52.7% |
| Market Status | Prescription |
| Company | Bracco |
| 4 of 6 | |
|---|---|
| Drug Name | Cystografin |
| Drug Label | Cystografin is a radiopaque contrast agent supplied as a sterile, clear, colorless to pale yellow, mobile or slightly viscous solution. Each mL provides 300 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of sol... |
| Active Ingredient | Diatrizoate meglumine |
| Dosage Form | Solution |
| Route | Urethral |
| Strength | 30% |
| Market Status | Prescription |
| Company | Bracco |
| 5 of 6 | |
|---|---|
| Drug Name | Cystografin dilute |
| Drug Label | Cystografin Dilute (Diatrizoate Meglumine Injection USP 18%) is a radiopaque contrast agent supplied as a sterile, aqueous solution. Each mL provides 180 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of soluti... |
| Active Ingredient | Diatrizoate meglumine |
| Dosage Form | Solution |
| Route | Urethral |
| Strength | 18% |
| Market Status | Prescription |
| Company | Bracco |
| 6 of 6 | |
|---|---|
| Drug Name | Sinografin |
| Drug Label | Sinografin (Diatrizoate Meglumine and lodipamide Meglumine Injection) is a sterile, nonpyrogenic, essentially colorless to pale yellow, aqueous radiopaque contrast medium for intrauterine instillation. Each mL provides 527 mg diatrizoate meglumine an... |
| Active Ingredient | Diatrizoate meglumine; iodipamide meglumine |
| Dosage Form | Solution |
| Route | Intrauterine |
| Strength | 26.8%; 52.7% |
| Market Status | Prescription |
| Company | Bracco |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;ORAL, RECTAL - 66%;10%
USFDA APPLICATION NUMBER - 11245
DOSAGE - SOLUTION;INTRAUTERINE - 52.7%;26.8%
USFDA APPLICATION NUMBER - 11324
DOSAGE - INJECTABLE;INJECTION - 66%;10%
USFDA APPLICATION NUMBER - 19292
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Taste Masking
Parenteral
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
